"Again, it is Cynata that has been involved in TWO articles THIS YEAR informing readers of the DETAILS of FDA TRIAL APPROVALS"
Correct, it's almost as though Cynata are currently engaged with the FDA regarding their Phase 2 GvHD trial.
"The OA trial is with the TGA. And Cynata yesterday stated that another trial will probably be required. Not might!"
Yes, again, not new information.
Now we know of another TGA P3 trial that Cynata was involved in until recently, don't we? Are you starting to get it?
No - please advise which P3 trial Cynata was also involved in recently
Why is another MSC ASX listed company dual listed on the NASDAQ? That was done YEARS ago.
Lock in 'because they were desperate for capital,' thanks Eddie.
And Ross has stated that the first to commercialise for Cynata will most likely be GVHD? Which is touted to be with the FDA but we know the P2 FDA trial has yet to start candidate enrolment and is 'months' away from doing so.
Context - first to commercialise in the US.
- Forums
- ASX - By Stock
- CYP
- Going forward...
CYP
cynata therapeutics limited
Add to My Watchlist
9.68%
!
17.0¢

Going forward..., page-1900
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
17.0¢ |
Change
0.015(9.68%) |
Mkt cap ! $38.41M |
Open | High | Low | Value | Volume |
15.5¢ | 17.0¢ | 15.5¢ | $47.10K | 289.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 23813 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.165 |
4 | 47240 | 0.155 |
4 | 161673 | 0.150 |
1 | 5000 | 0.145 |
2 | 45000 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 23813 | 3 |
0.175 | 55250 | 1 |
0.180 | 62619 | 3 |
0.185 | 35990 | 1 |
0.195 | 19300 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online